Welcome to our dedicated page for Amdocs SEC filings (Ticker: DOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amdocs Limited (NASDAQ: DOX) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Amdocs files annual reports on Form 20-F, which include consolidated financial statements, an operating and financial review, and detailed information on its business as a provider of software and services to communications, entertainment, and media service providers. The company also furnishes Form 6-K current reports containing quarterly financial information, earnings press releases, presentations, and proxy materials.
In its filings, Amdocs presents data on revenue, operating income, net income, earnings per share, free cash flow, and backlog, and explains the impact of phasing out certain low-margin, non-core business activities. The company uses both GAAP and non-GAAP financial measures and provides reconciliations, as shown in its Form 6-K for the quarter ended June 30, 2025 and in its fiscal 2025 earnings release furnished as an exhibit to a Form 6-K. These documents also discuss managed services revenue, cloud-related activities, and guidance ranges for future periods.
Amdocs’ SEC submissions include notices and proxy statements related to its annual general meeting of shareholders. In a Form 6-K, the company furnishes a notice of annual general meeting that outlines proposals such as the election of directors, amendments to the employee share purchase plan, approval of an increase in the dividend rate under its quarterly cash dividend program, approval of consolidated financial statements, and ratification of the independent registered public accounting firm. The proxy materials describe voting procedures, quorum requirements, and the use of notice-and-access for distributing proxy information.
Through this page, users can review Amdocs’ Form 20-F annual report for the year ended September 30, 2025, which is furnished as an exhibit to a Form 6-K, along with other Form 6-K reports that incorporate unaudited consolidated financial statements and earnings presentations. AI-powered summaries can help explain key sections of lengthy filings, highlight trends in revenue and profitability, and clarify the structure of Amdocs’ business and capital allocation policies. This makes it easier to interpret the company’s financial disclosures, governance proposals, and other regulatory information contained in its SEC filings.
Amdocs Limited submitted a Form 6-K as a foreign private issuer to make its annual report for the year ended September 30, 2025 available to investors. The company states that this annual report is furnished as Exhibit 99.1 to the Form 6-K and clarifies that the information is not deemed filed under Section 18 of the Exchange Act and is not incorporated by reference into other Securities Act or Exchange Act filings.
Amdocs Limited has called its annual general meeting for January 30, 2026, asking shareholders to elect 10 incumbent directors and approve several key proposals. Shareholders are asked to amend the 2023 Employee Share Purchase Plan to add 2,200,000 ordinary shares, increasing the plan reserve to 4,600,000 shares, which the company notes is about 2% of the 107,949,539 ordinary shares outstanding as of December 2, 2025.
The agenda also includes raising the quarterly cash dividend from $0.527 to $0.569 per share, following years of strong cash generation and share repurchases of approximately $489.5 million, $563.1 million and $551.3 million in fiscal 2023, 2024 and 2025. Shareholders are further asked to approve the fiscal 2025 consolidated financial statements and ratify Ernst & Young LLP as independent auditor for fiscal 2026, with the audit committee authorized to set its fees.
Amdocs Limited files its Form 20‑F annual report for the fiscal year ended September 30, 2025, describing its communications‑focused software and services business and key risks.
The company reports 108,448,276 ordinary shares outstanding as of year‑end, net of treasury shares, and notes that additional ordinary shares are reserved for stock options and restricted stock units. Revenue is highly concentrated: AT&T provided 25.9% of revenue in fiscal 2025 and 24.5% in 2024, while T‑Mobile contributed 19.9% and 22.6%, and the ten largest customers together represented approximately 70% of revenue in both years. The report highlights exposure to global economic conditions, intense industry competition, rapid shifts such as 5G, cloud and GenAI, cybersecurity and data‑privacy threats, heavy reliance on skilled staff, integration risks from acquisitions and partnerships, and complex international, ESG and AI regulatory regimes that could affect operations and growth.
Amdocs Limited submitted a Form 6-K as a foreign private issuer to furnish information about its latest quarterly results. The company reports that it issued a press release on November 11, 2025 announcing financial results for the quarter ended September 30, 2025, and attached that release and an earnings presentation as Exhibits 99.1 and 99.2. Amdocs specifies that the information in this report, including the exhibits, is furnished rather than filed under U.S. securities laws, meaning it is not subject to certain liability provisions and is not automatically incorporated into other securities filings.
Amdocs Limited (DOX) Form 144 notice: The filing reports a proposed sale of 2,285 shares of Common Stock through Citigroup Global Markets, Inc. (broker address provided) on 09/02/2025. The aggregate market value of the shares to be sold is listed as $195,367.50 and the total number of shares outstanding is reported as 110,000,000. The securities were acquired on 09/02/2025 by a stock option exercise and sale from AMDOCS LIMITED, and the stated nature of payment is compensation. The filer affirms, by signature, that they are not aware of any undisclosed material adverse information about the issuer.
Amdocs Limited discloses selected note items from its consolidated financial statements. Accumulated other comprehensive income (loss) components as of June 30, 2025 and 2024 include an unrealized gain on derivatives, net of tax, of $33,285 (2025) versus $587 (2024); an unrealized loss on short-term interest-bearing investments, net of tax, of $(1,739) (2025) versus $(8,805) (2024); and an unrealized loss on defined benefit plan, net of tax, of $(2,209) (2025) versus $(2,392) (2024). The company reports net-of-tax amounts of $2,485 and $622 for the three months ended June 30, 2025 and 2024, respectively, and $2,295 and $1,844 for the nine months ended June 30, 2025 and 2024, respectively. Available-for-sale securities classification changed between periods: as of June 30, 2025, $75,154 were short-term interest-bearing investments and $20,230 were cash and cash equivalents; as of September 30, 2024, $168,242 were short-term interest-bearing investments and $142,920 were cash and cash equivalents. The company references new accounting guidance on expense disaggregation effective for fiscal 2028 (annual) and 2029 (interim) and is evaluating its impact. It notes distributions of earnings to noncontrolling interests starting fiscal 2023 and discloses share repurchase authorizations totaling $2.1 billion (adopted Aug 2, 2023 and May 7, 2025) with an aggregate unused authorization of $1.12 billion. Certain items (foreign tax detail) are referenced but not specified in the excerpt.
Janus Henderson Group plc reports beneficial ownership of 5,795,194 ordinary shares of Amdocs Limited, representing 5.2% of the class. The filing shows shared voting and shared dispositive power for that stake, and no sole voting or dispositive power. An indirect subsidiary (JHIUS) is identified as a deemed beneficial owner of 5,794,432 shares and the filing states certain indirect subsidiaries are registered investment advisers providing advice to Managed Portfolios. The filing certifies these holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.